Journal Title：Clinical Drug Investigation

Clinical Drug Investigation provides rapid publication of original research covering all phases of clinical drug development and therapeutic use of drugs. The Journal includes:

-Clinical trials, outcomes research, clinical pharmacoeconomic studies and pharmacoepidemiology studies with a strong link to optimum prescribing practice for a drug or group of drugs.

-Clinical pharmacodynamic and clinical pharmacokinetic studies with a strong link to clinical practice.

-Pharmacodynamic and pharmacokinetic studies in healthy volunteers in which significant implications for clinical prescribing are discussed.

-Studies focusing on the application of drug delivery technology in healthcare.

-Short communications and case study reports that meet the above criteria will also be considered.

Additional digital features (including animated abstracts, video abstracts, slide decks, audio slides, instructional videos, infographics, podcasts and animations) can be published with articles; these are designed to increase the visibility, readership and educational value of the journal’s content. In addition, articles published in Clinical Drug Investigation may be accompanied by plain language summaries to assist readers who have some knowledge, but non in-depth expertise in, the area to understand important medical advances.

《臨床藥物調(diào)查》提供快速發(fā)表原創(chuàng)研究成果的服務(wù)，涵蓋臨床藥物開發(fā)和藥物治療用途的所有階段。該期刊包括：

-臨床試驗(yàn)、結(jié)果研究、臨床藥物經(jīng)濟(jì)學(xué)研究和藥物流行病學(xué)研究，與一種或一組藥物的最佳處方實(shí)踐密切相關(guān)。

-臨床藥效學(xué)和臨床藥代動力學(xué)研究，與臨床實(shí)踐密切相關(guān)。

-健康志愿者的藥效學(xué)和藥代動力學(xué)研究，其中討論了對臨床處方的重要影響。

-專注于藥物輸送技術(shù)在醫(yī)療保健中的應(yīng)用的研究。

-符合上述標(biāo)準(zhǔn)的簡短通訊和案例研究報告也將被考慮。

其他數(shù)字功能（包括動畫摘要、視頻摘要、幻燈片、音頻幻燈片、教學(xué)視頻、信息圖表、播客和動畫）可以與文章一起發(fā)布；這些旨在提高期刊內(nèi)容的知名度、讀者群和教育價值。此外，在《臨床藥物調(diào)查》上發(fā)表的文章可能附有通俗易懂的摘要，以幫助對該領(lǐng)域有一定了解但缺乏深入專業(yè)知識的讀者了解重要的醫(yī)學(xué)進(jìn)展。

Clinical Drug Investigation創(chuàng)刊于1989年，由Springer International Publishing出版商出版，收稿方向涵蓋醫(yī)學(xué) - 藥學(xué)全領(lǐng)域，此刊是中等級別的SCI期刊，所以過審相對來講不是特別難，但是該刊專業(yè)認(rèn)可度不錯，仍然是一本值得選擇的SCI期刊 。平均審稿速度 較慢,6-12周 ，影響因子指數(shù)2.9，該期刊近期沒有被列入國際期刊預(yù)警名單，廣大學(xué)者值得一試。